Importance Breast cancer will be diagnosed in 12% of women in the United States over the
course of their lifetimes and more than 250 000 new cases of breast cancer were diagnosed …

Purpose: Using a 2 2 factorial design, we studied the adjuvant chemotherapy of women with
axillary node–positive breast cancer to compare sequential doxorubicin (A), paclitaxel (T), …

Purpose To update the 2003 American Society of Clinical Oncology technology assessment
on adjuvant use of aromatase inhibitors. Recommendations Based on results from multiple …

… An Expert Panel, which included 51 members from 21 countries, chaired by Aron Goldhirsch
and Eric P. Winer met at the conclusion of the conference to review the new information …

The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial
new evidence on locoregional and systemic therapies for early breast cancer. Further …

Background Unresectable locally advanced or metastatic triple-negative (hormone-receptor–negative
and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is …

… This trial also demonstrated that the radioactive node count of a SLN is inversely proportional
to age (P … Another study of 966 patients included a multivariate analysis that suggested that …

Background The inhibition of cyclin-dependent kinases 4 and 6 (CDK4/6) could potentially
overcome or delay resistance to endocrine therapy in advanced breast cancer that is positive …

Background The 21-gene recurrence score assay is prognostic for women with node-negative,
oestrogen-receptor-positive breast cancer treated with tamoxifen. A low recurrence score …

The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this …